Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Provided By GlobeNewswire
Last update: Oct 30, 2024
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Inaugural Guggenheim Healthcare Conference.
Read more at globenewswire.com
